Vancomycin is a tricyclic
glycopeptide antibiotic derived from Amycolatopsis orientalis (formerly Nocardia orientalis) used for serious gram positive infections.
Nielsen, "Production of the
glycopeptide antibiotic A40926 by Nonomuraea sp.
Anaphylactoid reactions to
glycopeptide antibiotics. J Antimicrob Chemother.
Vancomycin is a
glycopeptide antibiotic that inhibits cell-wall synthesis and is primarily prescribed for patients with gram-positive infections.
Staphylococcus aureus resistance to the
glycopeptide antibiotic vancomycin is of noteworthy concern since vancomycin had been the only antibiotic to which there has been uniform susceptibility to multidrug-resistant Methicillin-resistant S.
In vitro activity of LY333328, an investigational
glycopeptide antibiotic, against enterococci and staphylococci.
The patient cohort, accumulated over 129 international sites, was divided into two arms, with 547 patients receiving ceftobiprole and 281 receiving the
glycopeptide antibiotic vancomycin plus the third-generation cephalosporin ceftazidime.
The patient cohort, accumulated over 129 international sites, was divided into two arms, with 547 patients receiving ceftobiprole (mean age 53 years) and 281 receiving the
glycopeptide antibiotic vancomycin plus the third-generation cephalosporin ceftazidime (mean age 52 years), according to the researchers.
Assembling the
glycopeptide antibiotic scaffold: the biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009.